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Abstract
Background: Small Ubiquitin-like MOdifier protein (SUMO) is a key regulator of nuclear functions but little is known
regarding the role of the post-translational modification sumoylation outside of the nucleus, particularly in the Central
Nervous System (CNS).
Methodology/Principal Findings: Here, we report that the expression levels of SUMO-modified substrates as well as the
components of the sumoylation machinery are temporally and spatially regulated in the developing rat brain. Interestingly,
while the overall sumoylation is decreasing during brain development, there are progressively more SUMO substrates
localized at synapses. This increase is correlated with a differential redistribution of the sumoylation machinery into
dendritic spines during neuronal maturation.
Conclusions/Significance: Overall, our data clearly demonstrate that the sumoylation process is developmentally regulated
in the brain with high levels of nuclear sumoylation early in the development suggesting a role for this post-translational
modification during the synaptogenesis period and a redistribution of the SUMO system towards dendritic spines at a later
developmental stage to modulate synaptic protein function.
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Introduction
Neurons are highly specialized cells whose connectivity at
synapses enables rapid information transfer in the brain. Synapse
formation and elimination as well as synaptic transmission and
plasticity largely depend on the correct targeting and arrangement
of complex protein networks on both sides of the synapse. These
networks are organized in an array of scaffolding and adaptors
molecules, presenting multiple protein-protein interaction do-
mains to anchor and position effectors such as neurotransmitter
receptors or components of signaling pathways and their
associated regulators. The structure and composition of synaptic
networks and effectors activities are highly regulated during
developmental processes and are also dynamically modified to
modulate synaptic transmission and plasticity. Recent develop-
ments in proteomics have provided a global identification of
proteins organizing these synaptic networks. However, the
spatiotemporal and functional regulation of these protein com-
plexes is still largely unknown. These dynamic processes are often
regulated by post-translational modifications (PTM) such as
phosphorylation or ubiquitination [1]. Interestingly, sumoylation
is now emerging as a potent post-translational mechanism to
regulate synaptic formation and plasticity.
Sumoylation was identified fifteen years ago [2] and consists in
the covalent labelling of the Small Ubiquitin-like MOdifier
SUMO (100 amino acid protein, ,11 kDa) to specific lysine
residues of target proteins. Four mammalian SUMO paralogs
(SUMO1-4) have been identified so far. SUMO1-3 are ubiqui-
tously expressed whereas SUMO4 is poorly characterized and
mainly expressed in kidney and spleen, [3,4,5]. SUMO2 and
SUMO3 are almost identical and referred as SUMO2/3. SUMO1
shares only 47% identity with SUMO2/3 and unlike SUMO2/3
cannot form poly-SUMO chains [6]#.
The covalent attachment of SUMO to target proteins is
mediated through an enzymatic cascade. SUMO precursors are
first matured by the hydrolase activity of desumoylation enzymes
called SENPs. Matured SUMOs are then activated for conjuga-
tion in an ATP-dependent manner by the specific SUMO E1-
activating complex formed by SAE1/SAE2 (also named AoS1/
Uba2). SUMO is transferred onto Ubc9, the unique E2-
conjugating enzyme of the system. Then, Ubc9 either directly or
in conjunction with one of the SUMO E3 ligating enzymes
catalyzes SUMO conjugation to specific lysine residues of target
proteins [3,5,7,8]. Despite covalent, sumoylation is readily
reversible due to the isopeptidase activity of the SENP enzymes
[9,10]. In humans, six SENPs (SENP1-3 and SENP5-7) have been
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distinct specificity towards SUMO paralogs [9,10].
Molecular consequences of sumoylation are multiple. Sumoyla-
tion may mask protein-protein interaction site, create new binding
interface or lead to conformational changes. Another interesting
emerging role for sumoylation in the CNS is the propensity to
regulate protein aggregation [11,12,13].
In neurons, SUMO modification influences various aspects of
neuronal activity [7,14,15]. Sumoylation was originally thought to
target nuclear proteins but it has become clear that it also has
important extranuclear roles and regulates the function of many
proteins including those involved in neurological disorders.
Sumoylation has also been shown to modify the stability and
activity of many transcription factors to regulate neuronal
morphogenesis and post-synaptic differentiation [16,17,18]. We
reported the presence of multiple unidentified sumoylation
substrates at synapses [19]#. This finding raises the intriguing
possibility that sumoylation may play important roles in brain
function. Since then, several cytosolic and plasma membrane
proteins important for neuronal excitability and synaptic trans-
mission were shown to be sumoylated, thereby modulating their
stability, subcellular targeting, transport or interacting properties
[20,21,22].
Although sumoylation regulates various key cellular processes,
the regulatory mechanisms of the SUMO system during brain
development are still largely unknown. Therefore, investigating
the temporal and spatial regulation of the SUMO system in the
developing brain is of particular interest to start unravelling the
functional roles of sumoylation in organizing neuronal networks.
Here, using brain fractionation experiments at various develop-
mental stages, we demonstrate that there is a developmental
regulation of both SUMO substrates and sumo-/desumoylation
enzyme expression levels. Moreover, immunocytochemical exper-
iments on primary cultures of rat hippocampal neurons reveal that
this developmental regulation is associated with a synaptic
redistribution of the sumoylation machinery during neuronal
maturation. Altogether, our data indicate that the sumoylation
process is highly regulated in the developing rat brain and very
active during period of synaptic formation and/or stabilization.
Results
Developmental regulation of SUMO substrates and
enzymes in the rat brain
The expression profiles of SUMO-modified substrates and some
of the existing SUMO enzymes have been investigated in a
number of cell lines e.g. SHSY5Y neuroblastoma [23]#, mouse
[24] and drosophila germ line cells [25]. However, the
developmental expression profile of protein sumoylation and the
spatiotemporal regulation of the components of the sumoylation
machinery in the brain have not been reported so far. We
therefore examine the expression levels of SUMO-modified
substrates and key sumoylation and desumoylation enzymes on
proteins extracted from whole rat brain at a series of age points
between the embryonic day E9 and the adult stage (Fig. 1).
Multiple SUMO-conjugated proteins were detected with
distinct SUMO1- and SUMO2/3-conjugated protein profiles at
all time point investigated (Fig. 1). Indeed, SUMO1-sumoylated
protein substrate immunoreactivity was detected early in the
development, with a sharp increase at E12 followed by a slow
decline to reach a relatively low level in the adult brain. SUMO2/
3-modified proteins were also developmentally regulated with a
two-phase expression profile peaking respectively at E12 and birth.
Covalent SUMO modification requires the free matured
SUMO to be activated prior to its conjugation to target proteins.
Specific enzymes are necessary to perform these successive
enzymatic steps i.e. the activating sumoylation complex AoS1/
Uba2 and the unique SUMO-conjugating enzyme Ubc9. We
show that the overall level of AoS1 remained almost unchanged
throughout the brain development period (Fig. 1). On the
contrary, the conjugation enzyme Ubc9 was developmentally
regulated and appears in two forms, a ,18 kDa unmodified free
Ubc9 and a ,40 kDa mono-sumoylated form of the enzyme on its
N-terminal lysine residue K
14 (Fig. S1 and [26,27]. Our data
clearly show a developmental switch from the non-sumoylated
Ubc9 early in the development to a SUMO-modified form of the
enzyme at a later maturation stage (Fig. 1). Interestingly, it was
reported that Ubc9 sumoylation could regulate SUMO target
discrimination [26]. Thus, this switching from the non-sumoylated
Ubc9 to a SUMO-modified form of the enzyme suggests that this
regulatory step also occurs in the developing rat brain to finely
modulate the specificity of protein sumoylation.
Despite being covalent, sumoylation is a reversible modification
through the action of specific desumoylation enzymes called
SENPs [10]#. SENP1 and SENP6 were chosen in this study
because they are the only two enzymes expressed throughout the
cells and not only in the nucleus or mitochondria as shown for
other members of the SENP family [10]. Both SENP1 and SENP6
enzymes were highly expressed early in the development and were
then decreased towards the adult stage (Fig. 1).
Together, these results suggest a role of the sumoylation
process during brain development. This control of the overall
protein sumoylation profile is occurring at ,E12 which
corresponds to the beginning of the synaptogenesis period in
the rat brain [28]. Furthermore, the concomitant developmental
regulation of sumoylation and desumoylation enzyme expression
Figure 1. Developmental regulation of the sumoylation
pathway in the rat brain. Representative developmental expression
profiles of SUMO1- and SUMO2/3-modified protein substrates and
sumoylation (AoS1, Ubc9) and desumoylation (SENP1 and SENP6)
enzymes. Whole rat brain homogenates at different ages, ranging from
the embryonic day E9 to the post-natal day P14 and the adult (Ad)
stage, were prepared in the presence of NEM to protect proteins from
desumoylation as described in the Method section. Lower panel shows
immunoblot of standard ß-actin loading control.
doi:10.1371/journal.pone.0033757.g001
Sumoylation in the Developing Rat Brain
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brain.
Developmental expression of SUMO-modified substrates
in the fractionated rat brain
To get further insight into the regulation of the SUMO system in
the CNS, we performed rat brain fractionation experiments (Fig.
S2) at various developmental stages to isolate nuclear, cytosolic
(Figs. 2,3) and synaptosomal fractions (Fig. 4). Subcellular
fractionation experiments were performed in the presence of
NEM to protect synaptic proteins from desumoylation. The analysis
of SUMO1- (Fig. 2A,B) and SUMO2/3- (Fig. 2C,D) conjugated
protein profiles reveal that although SUMO-mediated regulation
was so far mainly studied in the nucleus, the cytosolic fraction
contains a very substantial proportion of sumoylated proteins. In
addition, both nuclear and cytosolic sumoylated protein fractions
were developmentally regulated. SUMO1-sumoylated protein
expression level in nuclear and cytosolic fractions was similarly
regulated with a 14.2362.51 and 4.060.91 fold increase at E12
respectively, followed by a sharp decrease of sumoylation at E18 to
then steadily decline with comparatively little SUMO1-modified
substrates detected in adult brain (Fig. 2B). SUMO2/3-modified
substrate profile in the nucleus was similar to SUMO1-sumoylated
proteins with the highest level of expression detected at E12
(Fig. 2D; 5.9760.47 fold for SUMO2/3at E12 compared to
Adult). Interestingly, there was a differential regulationof SUMO2/
3-sumoylated protein pattern in the cytosol with no sumoylation
increase before birth but with a significant 2.8960.90 fold increase
at P3 compared to Adult. This disparity between SUMO1- and
SUMO2/3-sumoylation profiles reinforced the idea that there is a
SUMO-paralog specificity towards subcellular target proteins
during brain development.
Developmental regulation of the sumoylation machinery
in the fractionated rat brain
We next investigated whether the expression of sumoylation
(Fig. 3A) and desumoylation enzymes (Fig. 3B) was develop-
mentally regulated in the nuclear and cytosolic fractions described
Figure 2. SUMO-modified substrates are developmentally regulated in the fractionated rat brain. Representative immunoblots of
SUMO1- (A), SUMO2/3- (C) modified proteins in nuclear and cytosolic fractions obtained from fractionated rat brains at different developmental
stages. (B,D) Densitometric analysis was performed using Bio1D software (see Methods for details). Graphic representations normalized using ß-actin
loading controls show means 6 s.e.m. of at least five separate experiments. Statistical analyses were conducted with GraphPad Prism 4. One-way
ANOVA was performed with a Newman-Keuls post-test for multiple comparison data sets. *p,0.001 compared with other age points.
doi:10.1371/journal.pone.0033757.g002
Sumoylation in the Developing Rat Brain
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differentially regulated depending on their subcellular localisation.
In particular, immunodetection of the conjugation enzyme AoS1
in the nucleus was maximal at E12 with a 6.2360.09 fold increase
compared to adult nuclei. Then, the expression level of AoS1 was
slowly decreased throughout the development with very little
enzyme detected in adult brains. AoS1 was steadily expressed in
the cytosolic fraction at all time point investigated (Fig. 3A).
Strikingly, the two forms of the conjugating enzyme Ubc9 (free and
sumoylated SUMO-Ubc9) showed an inverted profile. The free non-
sumoylated Ubc9 was expressed early in the development, both in
the nuclear and cytosolic fractions whereas the non-sumoylated
Ubc9 expression levels were highest between E12 and E18 before
decreasing towards the adult stage. SUMO-Ubc9 showed the
converse profile with a progressive increased level of expression
that reached a maximum in adults in both compartments
(Fig. 3B).
Nuclear SENP1 was evenly expressed throughout the devel-
opment with relatively low expression levels compared to the
cytosolic fractions (Fig. 3C). The highest level of cytosolic
SENP1 expression was detected at E9, the earliest time point
assessed, with a significant 4.9660.84 fold increase compared to
Adult. SENP1 expression then dramatically decreased and
declined steadily with comparatively little enzyme detected in
adult brains. Nuclear SENP6 levels were low early in the
development at E9 and showed a peak of expression at E18 with
a significant 11.1162.82 fold increase compared to adult brains.
Cytosolic SENP6 expression levels were relatively steady
throughout the development (Fig. 3C).
Our data indicate that the components of the sumoylation
machinery are all expressed in synaptosomes suggesting that
sumoylation might directly regulate the function of many synaptic
proteins (Fig. 4). Moreover, synaptosomal expression levels of
SUMO-modified substrates and sumoylation machinery are
developmentally regulated (Fig. 4A). Interestingly, while the
nuclear and cytosolic levels of sumoylated substrates are decreased
in the adult brain, it was increased in the synaptosomal fraction
(Fig. 4). In synaptosomes, SUMO-modified protein levels were
significantly increased between E18 and P14 with a 2.4660.45
and a 1.7660.36 fold increase at P7 for SUMO1- and SUMO2/
3-sumoylated substrates respectively (Fig. 4A). AoS1 expression
level in synaptosomes was steady between E18 and P14 and then
significantly decreased in adults (Fig. 4B). Ubc9 and SUMO-
Ubc9 profiles were also inverted in synaptosomes with almost no
detectable free Ubc9 in adult synaptosomal fractions while
SUMO-Ubc9 levels increased by a significant 2.4360.49 fold in
matured brains (Fig. 4B). Desumoylation enzymes were also
detectable in synaptosomes although there were relatively little
SENPs expressed (Fig. 4C). SENP1 levels were low throughout
the development and maximum in adult whereas SENP6 levels
were higher at P7 and P14. SENP6 levels were decreased in adults
with relatively more SENP1 in adult synaptosomal fractions
(Fig. 4C).
Altogether, our data indicate that the SUMO system is highly
active early in the development, predominantly in the nuclear and
cytosolic compartments (Figs. 2,3) and that the sumoylation
machinery is then redistributed in synaptosomal fractions in more
matured brains (Fig. 4). Interestingly, in situ hybridization analysis
revealed high expression levels of Ubc9 mRNA in various regions
of the embryonic rat brain and a restricted expression of Ubc9
mRNA in adult brain mainly in cortical and hippocampal areas
[30]. Sumoylation may therefore be a way to regulate protein
Figure 3. Developmental regulation of the sumoylation machinery in the fractionated rat brain. Representative immunoblots of SUMO
enzymes AoS1 (A), Ubc9 (B) and SENP1/6 (C) in nuclear and cytosolic fractions obtained from fractionated rat brains at different developmental
stages. Densitometric and statistical analyses were performed as described in figure 2 legend and graphic representations show means 6 s.e.m. of
five independent experiments. (A) **p,0.001 compared with other age points and *p,0.05 compared with adult. (B) **p,0.01 compared with adult
and *p,0.001 compared with adult. (C) **p,0.01 compared with adult and *p,0.001 compared with other age points.
doi:10.1371/journal.pone.0033757.g003
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33757functions important for synaptogenesis in early developmental
stages and could also directly modulate synaptic transmission and/
or plasticity in more mature brains.
Synaptic redistribution of the sumoylation machinery
during neuronal maturation
To go further into the understanding of the neuronal
sumoylation system, we first showed that both SUMO1 and
SUMO2/3 immunoreactivities were detected in 10 and 20 DIV
hippocampal neurons with intense SUMO labelling in the nucleus
in agreement with the role of sumoylation in nuclear homeostasis.
Punctuate SUMO labelling was also clearly detectable along the
dendritic tree of both immature and mature neurons (Fig. S3). We
next analysed the synaptic redistribution of sumoylation and
desumoylation enzymes during neuronal maturation. Immunocy-
tochemical imaging of fixed permeabilized immature 10 DIV and
mature 20 DIV cultured hippocampal neurons revealed that all
SUMO enzymes investigated were expressed in the nucleus, soma,
dendrites and in synaptic structures (Figs. 5,6).
We measured a significant decrease of the SUMO activating
enzyme AoS1 immunoreactivity in Bassoon-positive presynaptic
structure (Fig. 5A; 0.5260.03 at 10 DIV compared to 0.3560.02
at 20 DIV) whereas the presynaptic distribution of Ubc9 remained
unaffected by the maturation process. The desumoylating enzymes
were similarly redistributed into presynaptic compartments
between 10 and 20 DIV with a 1.36 and 1.44 fold increase for
SENP1 and SENP6 immunoreactivity respectively (Fig. 5B).
We then observed that AoS1 was accumulated at Homer1-
positive postsynaptic sites with a ,2.1 fold increase (Fig. 6A;
0.1360.02 at 10 DIV compared to 0.2760.03 at 20 DIV). The
conjugation enzyme Ubc9 was also targeted into dendritic spines
in matured neurons with a significant 1.4 fold increase between 10
and 20 DIV (Fig. 6A; 0.1360.01 at 10 DIV compared to
0.1860.01 at 20 DIV). Interestingly, SENP1 and SENP6 show
opposite redistribution profiles. While the desumoylation enzyme
SENP1 localisation was decreased in dendritic spines of fully
matured neurons (Fig. 6B; 0.1360.01 at 10 DIV compared to
0.0760.01 at 20 DIV), SENP6 was significantly accumulated in
spines at 20 DIV (Fig. 6B; 0.1360.01 at 10 DIV compared to
0.1760.01 at 20 DIV). Our data reveal a differential redistribution
of SENP enzymes in post-synaptic areas that could point out
distinct target specificities for the two SENP enzymes during the
maturation process.
Discussion
Sumoylation is now seen as an important protein modification
for the regulation of many proteins in the CNS. Here, we focused
on two aspects of the sumoylation process in the CNS: the
developmental regulation of SUMO-modified protein and sumoy-
lation enzyme expression and the dendritic reorganization of
sumoylation and desumoylation enzymes during neuronal matu-
ration. We showed that the expression of the sumoylation
machinery is developmentally regulated in the rat brain.
Consistent with the known functions of sumoylation in the
regulation of nuclear homeostasis, we measured high SUMO1-
sumoylated substrate levels in the nucleus early in the develop-
ment. Many signalling pathways have been identified recently
linking neuronal activity to activity-regulated transcription factors
in neurons. This regulation at the gene expression level by
neuronal activity are involved in various aspects of brain
development, including but not restricted to dendritic branching,
synapse formation and stabilization or synapse elimination [31].
As an example, sumoylation of transcription factor Nr2e3 in
developing photoreceptors was shown to promote rod photore-
ceptor differentiation by converting Nr2e3 into a potent repressor
of cone-specific gene expression [18]. A further example comes
from the elegant work from Shalizi and colleagues demonstrating
Figure 4. Developmental regulation of the sumoylation
pathway in synaptosomal fractions. Representative immunoblots
of sumoylation AoS1 (A), Ubc9 (B) and desumoylation SENP1 and
SENP6 (C) enzymes in synaptosomal fractions obtained from fraction-
ated rat brains at different developmental stages. Data show means 6
s.e.m. of five separate experiments. One-way ANOVA was performed
with a Newman-Keuls post-test for multiple comparison data sets. (A)
**p,0.01 compared with E18 and P0 and p,0.05 compared with adult.
*p,0.05 compared with P7 and P14. (B) **p,0.05 compared with E18
and P0 and *p,0.01 compared with other age points. (C) **p,0.001
and *p,0.05 compared with other age points.
doi:10.1371/journal.pone.0033757.g004
Sumoylation in the Developing Rat Brain
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MEF2 (Myocyte Enhancer Factor 2) in the developing cerebellar
cortex. Following neuronal activation, there is a molecular switch
from MEF2A sumoylation to its acetylation leading to MEF2A
activation and inhibition of synapse formation [16,17].
For many years, sumoylation was believed to act only in the
nucleus. However it is now clear that it also serves important roles
outside of the nucleus (see, [3,8,15] for recent reviews). Here, our
data are in line with these reports with highest sumoylation levels
and SUMO enzyme expression early in the development followed
by a change in the subcellular distribution of these enzymes with
an enrichment in dendritic spines at more matured stages of the
brain development. Our current results are in agreement with our
previous work on the impact of sumoylation on kainate-receptor
mediated synaptic transmission where we reported that the
agonist-evoked sumoylation of the kainate receptor subunit GluR6
triggers their endocytosis and regulates synaptic transmission in
hippocampal slices [19]#.
SENP1 and SENP6 expression levels are also developmentally
regulated in the rat brain (Fig. 3,4) and these two desumoylases
present an inversed distribution in matured neurons (Fig. 5,6).
Interestingly, SENP1 exerts a preference towards SUMO1-
sumoylated proteins while SENP6 preferentially acts on SU-
MO2/3-conjugated substrates [9,10]. Despite these recent ad-
vances on the paralog specificity of the desumoylation enzymes,
little is still known about the dynamic regulation of the
sumoylation machinery, especially in neurons. However, the tight
balance between protein sumoylation and desumoylation as well as
Figure 5. Presynaptic redistribution of the sumoylation machinery during neuronal maturation. Confocal images show the
colocalisation (yellow) between the presynaptic marker Bassoon in green and in red, the sumoylation enzymes AoS1 and Ubc9 (A) or the
desumoylases SENP1 and SENP6 (B) in 10 and 20 DIV cultured rat hippocampal neurons. Enlargement of hatched areas are also depicted. Scale bars,
20 mm. Quantification of presynaptic colocalisation was performed using the ImageJ software as described in the methods. Histograms represent the
relative presynaptic intensity of the sumoylation machinery and each value is the mean 6 s.e.m. measured from 40 cells in four independent
experiments. (A) Student’s t-tests, *p,0.0001; n.s., not significant. (B) Student’s t-tests, *p,0.05 and **p,0.001.
doi:10.1371/journal.pone.0033757.g005
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an efficient way to dynamically modulate protein function at
synapses.
Persistence of a substantial pool of synaptic SUMO1- and
SUMO2/3-modified proteins and the synaptic distribution of the
whole sumoylation machinery in adult brains further suggests a
role for sumoylation in the regulation of synaptic function. For
instance, it has been demonstrated that sumoylation of presynaptic
proteins modulates neurotransmitter release. Increasing protein
sumoylation by entrapping recombinant SUMO1 in synaptosomes
decreased glutamate release evoked by KCl whereas decreasing
sumoylation with the catalytic domain of SENP1 enhanced KCl-
evoked release [29].
An additional exciting aspect in the SUMO field comes from
the existing crosstalk between sumoylation and ubiquitination
pathways [32,33]. Indeed, sumoylation has been shown to
compete with ubiquitination for the modification of the same
target lysine residues to protect proteins from degradation.
However it is now clear that this view of the interplay between
these two post-translational modifications is highly reductive
[33,34,35]. Indeed, several reports of the crosstalk between these
two PTMs for the functional regulation of the same target protein
are now available. As an example, several target proteins are
modified with poly-SUMO chains, thereby leading to the
detection by SUMO-targeted ubiquitin ligases (STUbLs), causing
the proteasomal degradation of these target proteins [36,37,38].
Figure 6. Postsynaptic relocalization of the sumoylation machinery during neuronal maturation. Confocal images show the
colocalisation (yellow) between the postsynaptic markers Homer1 or PSD-95 in green and in red, the sumoylation enzymes AoS1 and Ubc9 (A) or the
desumoylases SENP1 and SENP6 (B) in 10 and 20 DIV cultured rat hippocampal neurons. Enlargement of hatched areas are also depicted. Scale bars,
20 mm. Quantification of postsynaptic colocalisation was achieved using ImageJ. Histograms represent the relative postsynaptic intensity of
sumoylation enzymes and each value is the mean 6 s.e.m. measured from 40 cells in four independent experiments. (A) Student’s t-tests, *p,0.05
and **p,0.001. (B) Student’s t-tests, *p,0.01.
doi:10.1371/journal.pone.0033757.g006
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systeminthe CNS andthe synapticredistribution ofthe sumoylation
machinery during neuronal maturation as well as the wide diversity
of cellular functions regulated by this post-translational process, it is
not surprising to see more and more reports implicating the
sumoylation pathway in neurological disorders. A better under-
standingoftheSUMOsystemintheCNScouldundoubtedlyhelpto
unravel the pathogenic mechanisms of these diseases. Further work
will now be required to examine these possibilities.
Materials and Methods
Subcellular fractionation and synaptosomal preparation
Brain fractionations (Fig. S2) were performed as previously
described [19]#. Briefly, freshly dissected brains from Embryonic
E9, E12, E15, E18 and Post-natal P0, P3, P7, P14 or adult Wistar
rats (Janvier, Saint Berthevin, France) were homogenized in ice-
cold sucrose buffer (10 mM Tris-HCl pH 7.4, 0.32 M sucrose,
standard mammalian protease inhibitors (Sigma-Aldrich, Saint
Quentin Fallavier, France) containing 20 mM NEM (Sigma-
Aldrich) to protect modified proteins from desumoylation).
Nuclear fractions were pelleted by centrifugation at 1,000g for
10 min. Post-nuclear S1 fractions were further centrifuged at
10,000g for 20 min to give the crude synaptosomal P2 fractions
and the supernatant S2 fractions. Synaptosomes were then
purified from the P2 fraction by centrifugation at 40,000g for
2 hours on discontinuous step gradients consisting of 1.2, 0.8,
0.32M sucrose. The synaptosomal fraction from the 0.8–1.2 M
sucrose interface was collected and resuspended in lysis buffer
(10 mM Tris-HCl pH 7.5, 10 mM EDTA, 150 mM NaCl, 1%
Triton X100, 0.1% SDS) in presence of protease inhibitors and
NEM as before. Protein concentration was determined (Bio-Rad,
Marne-la-Coquette, France) and then proteins adjusted to 1 mg/
mL in reducing sample buffer and boiled for 10 min.
Sample proteins (30 mg) were resolved by SDS–PAGE, electro-
transferred onto nitrocellulose membranes as described before [19]
and immunoblotted with the following primary antibodies: rabbit
anti-SUMO1 (1/1000; [39,40], rabbit anti-SUMO2/3 (1/240;
Invitrogen, Carlsbad, CA, USA), mouse anti-Ubc9 (1/200, BD
Bioscience, Rungis, France), goat anti-AoS1, rabbit anti-SENP1
and goat anti-SENP6 (1/200, Santa Cruz Biotechnology, Santa
Cruz, CA, USA). Standard ß-actin controls were included in each
experiment using a mouse anti-ß-actin antibody (Sigma, Saint
Quentin Fallavier, France). Intensities of bands were quantified
using Bio1D software (Vilber-Lourmat, Marne-la-Valle ´e, France).
Densitometric values for SUMO-modified proteins (ranging from
35 and 250 kDa) measured from each entire lane were compared to
the corresponding adult’s brain fractions (figures 2 and 3) or to the
corresponding E18 values (figure 4).
Dispersed hippocampal neuronal cultures
Primary hippocampal cultures were prepared from E18
pregnant Wistar rats as previously described [41,42]. Cells were
plated in Neurobasal medium (Invitrogen, Villebon sur Yvette,
France) supplemented with 2% B27 (Invitrogen), 0.5 mM
glutamine, 12.5 mM glutamate and penicillin/streptomycin on
24-mm glass coverslips pre-coated with poly-L-lysine (0.1 mg/
mL). Neurons (100,000 cells per coverslip) were then fed once a
week for 3 weeks in Neurobasal medium (Invitrogen) supplement-
ed with 2% B27 (Invitrogen) and penicillin/streptomycin.
Immunocytochemistry
Hippocampal neurons were rinsed twice in phosphate-buffered
saline (PBS) and then fixed with PFA 4% in PBS for 10 min at
room temperature (RT). Fixed cells were permeabilised for 20 min
in PBS containing 0.1% Triton X100 and 10% Horse Serum (HS)
at RT. Neurons were then incubated as indicated on the figures
with a combination of goat anti-AoS1, mouse anti-Ubc9 or goat
anti-SENP6 antibodies (1/50), rabbit anti-Homer1 (1/200;
Synaptic System, Gottingen, Germany), rabbit anti-Bassoon (1/
200; Stressgen), rabbit anti-SENP1 (1/50) and mouse anti-PSD-95
(1/100; NeuroMab, Davis, CA, USA) overnight at 4uC in PBS
containing 0.05% Triton X100 and 5% HS. Cells were washed
three times 10 min in PBS and incubated with the appropriate
secondary antibodies conjugated to either Alexa488 or Alexa594
in PBS containing 5% HS with 0.05% Triton X100 for 1 h at RT,
washed three times in PBS and mounted with Mowiol (Sigma)
before confocal examination.
Image analysis
Sequential confocal images (102461024 pixels) were acquired
with a 636 oil-immersion lens (Numerical Aperture, 1.4) on an
inverted TCS-SP5 confocal microscope (Leica Microsystems,
Nanterre, France). Z-series of 7–8 images of randomly chosen
dendrites were compressed into two dimensions using the
maximum projection algorithm of the Leica software. Quantifi-
cation was performed using the ImageJ 1.42 software (NIH, USA)
and the synaptic enzymatic staining was measured with the use of
an in-house ImageJ macro. Briefly, confocal images of synaptic
marker were used to produce masks after an automated intensity
threshold. Masks were applied to the corresponding sumoylation/
desumoylation enzyme images and the fluorescence intensity
within the synaptic area was measured.
Statistical analysis
The N used for statistical analysis was either the number of
animals, the number of experiments or the number of cells and is
indicated in the figure legends. Statistical analyses were calculated
using Prism 4 (GraphPad software, Inc., La Jolla, CA, USA). Data
were expressed as mean 6 s.e.m.. Unpaired Student’s t-tests or
one-way ANOVA were performed with a Newman-Keuls post-test
for multiple comparison data sets when required.
Supporting Information
Figure S1 Ubc9 is highly sumoylated in adult rat brain
homogenates. (A) Immunoprecipitation experiments using anti-
Ubc9 antibody revealed that Ubc9 is abundantly sumoylated in
adult brain homogenates. Control IgG antibodies were also used
here as a control for immunoprecipitation. Heavy (hc) and light (lc)
IgG chains are indicated on the figure. (B) Ubc9 immunoblot on
brain protein extracts obtained in the absence or in the presence of
20 mM NEM (to protect SUMO-modified proteins from desumoylation
during cell lysis) showed that the amount of sumoylated Ubc9 is
reduced in the absence of NEM with the concurrent increase of
the 18 kDa non-sumoylated Ubc9 band intensity further demon-
strating that Ubc9 is sumoylated in neurons.
(TIF)
Figure S2 Subcellular rat brain fractionation. (A) Sche-
matic of the subcellular fractionation protocol utilized to collect
the nuclear, cytosolic and synaptic fractions. (B) Immunoblots
showing the synaptic PSD-95 protein, nuclear HDAC3 marker
and control ß-actin labelling to assess brain fractionation.
(TIF)
Figure S3 SUMO1 and SUMO2/3 labelling in immature
and mature rat hippocampal neurons. SUMO1 and
SUMO2/3 labelling in 10 or 20 DIV rat hippocampal neurons.
Sumoylation in the Developing Rat Brain
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33757Note that the SUMO labelling is intense within the nucleus in
agreement with the role of sumoylation in the control of nuclear
homeostasis. Interestingly, SUMO immunoreactivity was also
detected as a punctuate staining in the dendritic tree of immature
and mature neurons. Scale bars, 20 mm.
(TIF)
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